Table 3.
Serial Dilution Experiments for Mutation Detection With MitoChip
RCRS base # | Sequence in lymphocyte DNA | Sequence in pure tumor DNA | Sequence in 1:50 diluted tumor DNA |
---|---|---|---|
750 | G | A | A + G |
1007 | G | A | A + G |
2000 | C | T | C + T |
2352 | T | C | C + T |
4655 | G | A | A + G |
5262 | G | A | A + G |
5421 | G | A + G | No calla |
6524 | T | C | No calla |
8701 | A | G | A + G |
9540 | T | C | C + T |
9547 | G | G + T | No call |
10398 | A | G | A + G |
10873 | T | C | No calla |
11180 | G | A + G | A + G |
11350 | A | G | A + G |
12248 | A | G | A + G |
12705 | C | T | C + T |
13101 | A | C | A + C |
13197 | C | T | C + T |
13650 | C | C + G | No call |
14212 | T | C | C + T |
14766 | C | T | C + T |
15812 | G | A | A + G |
15904 | T | C | C + T |
Heterozygous call is present at these three nucleotide positions (5421 = A + G; 6524 = C + T; 10873 = C + T) in the 10-fold diluted tumor DNA sample